Shares of Elite Pharmaceuticals, Inc. ELTP have lost 3.3% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 Index’s 1.2% gain over the same time ...

In the second quarter of fiscal 2026, Elite Pharmaceuticals posted revenues of $36.3 million, up 92.4% year over year from $18.9 million, driven largely by the launch and rapid expansion of its ...

Elite Pharmaceuticals Inc. Annual cash flow by MarketWatch. View ELTP net cash flow, operating cash flow, operating expenses and cash dividends.

Two biotech companies had a rough end to the week last week, and it looks as though things aren’t going to get much better for them heading into the US open on Monday. Here’s what happened. Of the two ...

**NM signifies a non meaningful value. A dash signifies the data is not available.